{ "_description": "IJT 반증 반영 모델 수정(ARM-2 Wnt겹침 overlap) + 독립축 재예측. 시너지는 직교축 쌍에서만 생존; 피나×미녹은 겹침→가법미만(관측 정합).", "diagnosis": "미녹시딜 Wnt/β-catenin 활성 → 피나와 W축 겹침 → 원 모델의 독립가정 위반.", "revision": "ARM-2에 W-겹침 overlap 도입: e_W=1−(1−e1)(1−e2·overlap), e_D=e2(1−overlap).", "overlap_sweep": [ { "overlap": 0.0, "R1": 0.386, "R2": 0.242, "R_combo": 0.657, "bliss_expected": 0.535, "synergy_excess": 0.122 }, { "overlap": 0.2, "R1": 0.424, "R2": 0.333, "R_combo": 0.689, "bliss_expected": 0.616, "synergy_excess": 0.073 }, { "overlap": 0.4, "R1": 0.471, "R2": 0.425, "R_combo": 0.725, "bliss_expected": 0.696, "synergy_excess": 0.03 }, { "overlap": 0.5, "R1": 0.499, "R2": 0.472, "R_combo": 0.746, "bliss_expected": 0.735, "synergy_excess": 0.011 }, { "overlap": 0.6, "R1": 0.532, "R2": 0.519, "R_combo": 0.77, "bliss_expected": 0.775, "synergy_excess": -0.005 }, { "overlap": 0.8, "R1": 0.617, "R2": 0.622, "R_combo": 0.828, "bliss_expected": 0.855, "synergy_excess": -0.027 }, { "overlap": 1.0, "R1": 0.744, "R2": 0.744, "R_combo": 0.909, "bliss_expected": 0.934, "synergy_excess": -0.025 } ], "synergy_crosses_zero_near": 0.6, "pair_predictions": { "피나 × 미녹시딜(부분겹침)": { "overlap": 0.55, "R1": 0.515, "R2": 0.495, "R_combo": 0.758, "bliss_expected": 0.755, "synergy_excess": 0.003, "verdict": "가법" }, "AR차단 × Wnt-agonist(완전중복=둘다 W)": { "overlap": 1.0, "R1": 0.744, "R2": 0.744, "R_combo": 0.909, "bliss_expected": 0.934, "synergy_excess": -0.025, "verdict": "가법미만" }, "W축 약물 × 순수 D약물(직교, Wnt무관)": { "overlap": 0.0, "R1": 0.386, "R2": 0.242, "R_combo": 0.657, "bliss_expected": 0.535, "synergy_excess": 0.122, "verdict": "초가법(synergy)" } }, "new_falsifiable_prediction": "초가법 시너지는 *기전적으로 직교(한쪽 Wnt 무관 D-제제)* 인 쌍에서만 발생. 피나×미녹 같은 부분겹침 쌍은 가법미만(IJT 2023 관측과 일치).", "honest": "overlap은 반증이 가르쳐준 모델 수정(자유예측 아님). 새 예측은 진짜 직교 약물쌍 전향 검정 필요. 미녹 Wnt활성은 문헌 근거(예: 미녹시딜→DP β-catenin↑)." }